Drugs / 99mTc-Macro Albumin Aggregate
99mTc-Macro Albumin Aggregate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05848947 | Apr → Jul 2023 | hepatocellular carcinoma | Sirtex Medical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-Macro Albumin Aggregate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05848947 ↗ |
| Known as | 99mTc-MAA | “Technetium-99m macroaggregated-albumin (99mTc-MAA)” NCT05848947 ↗ |
| Known as | Technetium-99m macroaggregated-albumin | “Technetium-99m macroaggregated-albumin (99mTc-MAA)” NCT05848947 ↗ |